← Leaderboards
Sandi Leigh Pruitt
Ut Southwestern Medical Center
$5,575,909
Attributed
$7,081,378
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2015–25$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,081,378 · 4
By mechanism
R01$5,735,214 · 2
P30$1,184,455 · 1
R03$161,709 · 1
Top collaborators
- Salma Shariff-Marco5 shared
- David Eric Gerber2 shared
Most similar at Ut Southwestern Medical Center
Same institution · by research overlap
- Amit Singal$17,388,983
- Adam Yopp$5,283,383
- David Dwight Rahn$5,198,863
- David Eric Gerber$9,524,578
- Jasmin Anita Tiro$7,604,681
Others in their field
Top investigators on “Cancer Type”
- David Heimbrook · Leidos Biomedical Research, Inc.$244,136,322
- Larry Arthur$156,041,271
- Peter C Adamson · National Childhood Cancer Foundation$114,476,581
- Richard K. Wilson · Washington University$85,800,013
- Gregory H Reaman · National Childhood Cancer Foundation$62,692,489
- Mitchell D Schnall · University Of Pennsylvania$57,847,967
Research focus
Cancer TypeResearch PersonnelMalignant NeoplasmsEvidence BaseColorectal CancerMalignant Breast NeoplasmPopulation BasedDiagnosisInfrastructureLinkStage At DiagnosisClinical TrialsPoliciesMalignant Neoplasm Of LungMortalityColorectalBreastAdultCancer CareMemberCancer Health DisparityCharacteristicsCommunity OutreachCancer Patient
Grant awards (16)
Community Outreach and Engagement$243,163
P30 · FY2025 · CA · contact PI
Ethnicity and Nativity in Cancer - Latino & Asian Enclaves: The ENCLAVE Study$528,556
R01 · FY2024 · CA
Community Outreach, Engagement, and Equity$470,646
P30 · FY2024 · CA · contact PI
Ethnicity and Nativity in Cancer - Latino & Asian Enclaves: The ENCLAVE Study$545,244
R01 · FY2023 · CA
Community Outreach, Engagement, and Equity$470,646
P30 · FY2023 · CA · contact PI
Revisiting Prior Cancer as an Exclusion Criterion for Cancer Clinical Trials$371,267
R01 · FY2023 · CA · contact PI
Revisiting Prior Cancer as an Exclusion Criterion for Cancer Clinical Trials$647,891
R01 · FY2022 · CA · contact PI
Ethnicity and Nativity in Cancer - Latino & Asian Enclaves: The ENCLAVE Study$557,725
R01 · FY2022 · CA
Revisiting Prior Cancer as an Exclusion Criterion for Cancer Clinical Trials$657,592
R01 · FY2021 · CA · contact PI
Ethnicity and Nativity in Cancer - Latino & Asian Enclaves: The ENCLAVE Study$588,467
R01 · FY2021 · CA
Ethnicity and Nativity in Cancer - Latino & Asian Enclaves: The ENCLAVE Study$629,237
R01 · FY2020 · CA
Revisiting Prior Cancer as an Exclusion Criterion for Cancer Clinical Trials$283,509
R01 · FY2020 · CA · contact PI
Revisiting Prior Cancer as an Exclusion Criterion for Cancer Clinical Trials$537,213
R01 · FY2019 · CA · contact PI
Revisiting Prior Cancer as an Exclusion Criterion for Cancer Clinical Trials$388,513
R01 · FY2018 · CA · contact PI
Evaluating prior cancer exclusion policy to increase lung cancer trial accrual$80,959
R03 · FY2016 · CA
Evaluating prior cancer exclusion policy to increase lung cancer trial accrual$80,750
R03 · FY2015 · CA